Experimental and theoretical studies of the photophysics of 7-amino-3-phenyl-2H-benzo[b] [1,4]oxazin-2-one in homogeneous solvents and b-cyclodextrin aqueous solutions

The photophysical behavior of 7-amino-3-phenyl-2Hbenzo[b][1,4]oxazin-2-one was studied in organic solvents and in aqueous solutions of b-cyclodextrin using steady-state fluorescence and computational chemistry methods. In homogeneous media, fluorescence spectra show a noteworthy solvatochromic effect leading to large Stokes shifts. Linear solvation energy relationship and Lippert-Mataga equation analysis of the Stokes shifts indicate an increase of the dipolar moment in the singlet excited state and the participation of a partial chargetransfer state in the deactivation process. Incorporation of 7-amino-3-phenyl-2H-benzo[b][1,4]oxazin-2-one into the b-cyclodextrin inner cavity was monitored by observing the increase of fluorescence as a function of the cyclodextrin concentration. Analysis of fluorescence data in terms of Job plots and the Benesi-Hildebrand equation are indicate the formation of a 1:1 complex. The binding constantobtained from Benesi-Hildebrand plots was 597 M-1 at 298K. Also, the values of thermodynamics parameters determinedfrom the dependence of the binding constant on thetemperature show that inclusion is an enthalpy-driven process.Docking studies suggest that the complex stability is due to favorable van der Waals interactions within the cavity and a hydrogen bond interaction between the amino substituent and hydroxyl groups located in the narrow rim of the cavity. The same conclusion was achieved employing the Molecular Mechanics Poisson-Boltzmann Surface Area methodology to determine the energy contributions to the total free energy for the inclusion process

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p<0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (<1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (<1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

13C-NMR and theoretical studies of internal rotation in methylated anilines

The conformational properties of ten ring-methylated N-methyl- and N,N-dimethylanilines have been studied using 13C-NMR chemical shifts and spin-lattice relaxation times in CDCl3, and semi-empirical (AM1) quantum-chemical calculations. The experimental results indicate that, like aryl methyl ethers, N-methylanilines prefer conformations in which the N-methyl carbon lies near the ring plane. Ortho-substitution in these compounds, while forcing the N-methyl group to adopt an anti orientation with regard to the ortho substituent, does not induce any important changes from the vantage point of the electron donor ability of the amine function and therefore does not affect the N-methyl 13C chemical shifts or spin-lattice relaxation times to any appreciable extent. The preferred conformations of ortho-unsubstituted N,N-dimethylanilines leave the N-methyl carbon atoms oscillating on either side of the ring plane, but the conformational space of these compounds is strongly limited by ortho-met

Molecular modeling of the α9α10 nicotinic acetylcholine receptor subtype

This study reports the comparative molecular modeling, docking and dynamic simulations of human α9α10 nicotinic acetylcholine receptors complexed with acetylcholine, nicotine and α-conotoxin RgIA, using as templates the crystal structures of Aplysia californica and Lymnaea stagnalis acetylcholine binding proteins. The molecular dynamics simulations showed that Arg112 in the complementary α10(-) subunit, is a determinant for recognition in the site that binds small ligands. However, Glu195 in the principal α9(+), and Asp114 in the complementary α10(-) subunit, might confer the potency and selectivity to α-conotoxin RgIA when interacting with Arg7 and Arg9 of this ligand. © 2008 Elsevier Ltd. All rights reserved

Theoretical study of the interaction d10-s2 between Pt(0) and Tl(I) on the [Pt(PH3)3Tl]+ complex

We studied the attraction between [Pt(PH3)3] and Tl(I) in the [Pt(PH3)3]-Tl+ complex using ab initio methodology. We found that the changes around the equilibrium distance Pt-Tl and in the interaction energies are sensitive to the electron correlation potential. This effect was evaluated using several levels of theory, including HF, MPn (n = 2-4), CCSD and CCSD(T). The obtained interaction energies differences at the equilibrium distance Re (Pt-Tl) range from 134 to 205 kJ/mol at the different levels used. At long-distances, the behaviour of the [Pt(PH3)3]-Tl+ interaction may be related mainly to charge-induced dipole and dispersion terms, both involving the individual properties of [Pt(PH3)3] and thallium ion. However, the charge-induced dipole term (R-4) is found as the principal contribution in the stability at the long and short distances. The dispersion interaction is smaller, but not negligible near equilibrium distance. © 2005 Elsevier B.V. All rights reserved

Probing the hydride transfer process in the lumiflavine-1- methylnicotinamide model system using group softness

The hydride transfer process between the isoalloxazine moiety of flavins and the nicotinamide moiety of NAD(P)H has been explored by using density functional theory based reactivity index in the 1-methylnicotinamide-lumiflavine model system. Based on crystallographic data available, we have found that the group softness index helps to locate and orientate reactive regions in these interacting molecules while the electrophilicity index successfully describes the reactivity pattern of this system. © 2004 Elsevier Ltd. All rights reserved

Basicity and solvent effects on hydrogen bonding in NR3 ⋯ HCOOH (R = H, CH3) model systems

The effect of the basicity of methyl-amines on hydrogen bonding (HB) with HCOOH is examined in both gas and solution phases. In the gas phase, the strength of HB may be related to the proton affinity (PA) difference between the carboxylate anion and the methyl-amine, ΔPA = PA(HCOO-) - PA(NR3). The changes in the driving potential ΔPA are explained on the basis of electronic substituent effects. The electronic substituent effects are rationalized in terms of local reactivity indices such as the Fukui function and the local hardness and softness at the basic center. A simple model is then proposed to explain the enhancement HB in the solution phase. The HB pattern in the solution phase is changed by electrostatic and nonelectrostatic solvation of the zwitterionic and neutral species in equilibrium. © 1999 John Wiley & Sons, Inc